£1.9M
The funding round was led by Technology Venture Partners alongside government backing to support the commercialisation of a new breast scanning system.
Micrima develops a radio-wave breast scanning system for early cancer detection.
Micrima is a commercial stage company that develops a radiofrequency imaging system for early breast cancer diagnosis. The firm has established distribution channels in Germany, Austria and Switzerland.
Nick Randall
Chairman

Adrian Waller
CEO
Adrian brings medical device and enterprise leadership experience, having previously served as general manager at Fujifilm UK and chief executive officer at Micrima Limited.
LinkedInThe funding round was led by Technology Venture Partners alongside government backing to support the commercialisation of a new breast scanning system.